Showing results (251-260 of 527) with videos related to

Sort By:
Pageof 53
Plos One|September 30, 2014
Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trialUzma N Sarwar, Laura Novik, Mary E Enama, et al.
Virus Research|November 4, 2004
Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003Alexander C Schmidt, Teresa R Johnson, Peter J M Openshaw, et al.
Science Immunology|January 24, 2017
Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donorsMorgan S A Gilman, Carlos A Castellanos, Man Chen, et al.
Vaccine|November 28, 2006
Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individualsJanie Parrino, Lewis H McCurdy, Brenda D Larkin, et al.
Nature Communications|November 30, 2017
Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion stateIebe Rossey, Morgan S A Gilman, Stephanie C Kabeche, et al.
Nature|February 3, 2017
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccinationNorbert Pardi, Michael J Hogan, Rebecca S Pelc, et al.
Lancet (London, England)|December 9, 2017
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trialsMartin R Gaudinski, Katherine V Houser, Kaitlyn M Morabito, et al.
Cell Chemical Biology|March 1, 2022
Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivoGeorge I Georgiev, Ryan J Malonis, Ariel S Wirchnianski, et al.
Vaccine|February 13, 2025
Evaluation of a nanoparticle influenza vaccine in the pig modelPauline M van Diemen, Fabian Z X Lean, Andrew Ramsay, et al.
Immunity|February 4, 2018
Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic HypermutationEileen Goodwin, Morgan S A Gilman, Daniel Wrapp, et al.
Pageof 53